In this work, we will review the existing experimental and epidemiological evidence implicating dysregulation of the receptor activator of nuclear factor-κB (RANK) signaling pathway in the predisposition to breast cancer among women with an inherited BRCA1 mutation. The gene discussed is BRCA1; the disease is breast carcinoma.